“Association between C-Reactive Protein and Macular Degeneration”, JAMA, vol. 291, pp. 704-710, 2004.
, “Change in Area of Geographic Atrophy in the Age-Related Eye Disease Study: AREDS Report Number 26”, Arch Ophthalmol, vol. 127, pp. 1168-1174, 2009.
, “Change in Area of Geographic Atrophy in the Age-Related Eye Disease Study: AREDS Report Number 26”, Arch Ophthalmol, vol. 127, pp. 1168-1174, 2009.
, “C-Reactive Protein and Homocysteine are Associated With Dietary and Behavioral Risk Factors for Age-Related Macular Degeneration”, Nutrition, vol. 22, pp. 441-443, 2006.
, “Genome-Wide Association Identifies SKIV2L and MYRIP as Protective Factors for Age-Related Macular Degeneration”, Genes Immun, vol. 11, pp. 609-621, 2010.
, ,
,
“Natural History of Drusenoid Pigment Epithelial Detachment in Age-Related Macular Degeneration: Age-Related Eye Disease Study Report No. 28”, Ophthalmology, vol. 117, pp. 489-499, 2010.
, “Progression of Geographic Atrophy and Genotype in Age-Related Macular Degeneration”, Ophthalmology, vol. 117, pp. 1554-1559, 1559 e1551, 2010.
, “Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers”, J Infec Dis, vol. 183, pp. 1343-52, 2001.
“Secondary Analyses of the Effects of Lutein/Zeaxanthin on Age-Related Macular Degeneration Progression: AREDS 2 Report Number 3”, JAMA Ophthalmol, vol. 132, no. 2, pp. 142-149, 2014.
, “Serum Nutrient Levels as Risk Factors for Neovascular AMD”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2005.
,